The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1163585
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense desmoplastic stroma that impedes drug delivery, reduces parenchymal blood flow, and suppresses the anti-tumor immune response. The extracellular matrix and abundance of stromal cells result in… read more here.
Keywords: adenosine signaling; adora2b receptor; adora2b; receptor ... See more keywords